Tyrosine Kinase Inhibitors: all 10,479 studies that test it
Page 70 of 105. Open to participants first (1,915), then studies with results posted, then the rest; newest registration first within each.
- Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBCStatus unknownNCT03910712Phase 2
- Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma AnnulareCompletedNCT03910543Phase 1
- Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）Status unknownNCT03910127Phase 1
- Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC)Status unknownNCT03909724Phase 2/3
- Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line TherapyCompletedNCT03906058Phase 2
- A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell CarcinomaTerminatedNCT03905889Phase 1
- Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid TumorsCompletedNCT03905148Phase 1
- A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLCStatus unknownNCT03904823Phase 2
- CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)Status unknownNCT03904719Phase 2
- : A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid TumorsCompletedNCT03903705Phase 1/2
- A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's SyndromeActive, not recruitingNCT03899337Phase 2
- Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia AreataActive, not recruitingNCT03898479Phase 2/3
- Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid TumorsStatus unknownNCT03897283Phase 1
- Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary TumorsCompletedNCT03895970Phase 2
- A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian CancerStatus unknownNCT03895788Phase 1
- PONAZA : A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISISCompletedNCT03895671Phase 2
- A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's LymphomasTerminatedNCT03893682Phase 1
- Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung CancerTerminatedNCT03891615Phase 1
- An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver DamageCompletedNCT03890809Phase 1
- A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.CompletedNCT03890770Phase 1
- Anlotinib Maintenance Treatment for Advanced Soft Tissue SarcomaCompletedNCT03890068Phase 2
- Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib HydrochlorideStatus unknownNCT03890055Phase 4
- The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric CancerStatus unknownNCT03889626Phase 3
- Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene AmplificationCompletedNCT03888092Phase 1/2
- A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I MutationStatus unknownNCT03883100Phase 2
- A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I MutationStatus unknownNCT03883087Phase 2
- Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid LeukemiaCompletedNCT03882281Phase 1
- Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue SarcomaStatus unknownNCT03880695Phase 2
- Food Effect Study of CTP-543 in Healthy VolunteersCompletedNCT03880136Phase 1
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Neoadjuvant Immunotherapy for Resectable Gastric CancerCompletedNCT03878472Phase 2
- A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCCTerminatedNCT03876925Phase 1/2
- Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma PatientsTerminatedNCT03876028Phase 1
- Phase I Trial of Defactinib and VS-6766.Active, not recruitingNCT03875820Phase 1
- A Study of Full Treatment-free Remission in Patients With Chronic Myeloid LeukemiaTerminatedNCT03874858Phase 2
- Study of Crizotinib in Children and Adolescents With Myofibroblastic TumorsStatus unknownNCT03874273Phase 2/3
- A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma PatientsStatus unknownNCT03873532Phase 2/3
- Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy MalesCompletedNCT03873415Phase 1
- Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in ChildrenStatus unknownNCT03868852Phase 1/2
- Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid CancersWithdrawnNCT03868423Phase 2
- Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy VolunteersCompletedNCT03868072Phase 1
- A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer PatientsStatus unknownNCT03866499Phase 3
- MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtibActive, not recruitingNCT03865511Phase 2
- A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast CancerStatus unknownNCT03863223Phase 3
- Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib TreatmentStatus unknownNCT03862768Not applicable
- D-0316 in Patients With EGFR Positive Non Small Cell Lung CancerCompletedNCT03861156Phase 2
- Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR MutationStatus unknownNCT03856697Phase 3
- Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid TumorsActive, not recruitingNCT03851614Phase 2
- Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)Active, not recruitingNCT03850964Phase 2/3
- CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).Status unknownNCT03848611Phase 2
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast CancerStatus unknownNCT03847818Not applicable
- Tucatinib + Abemaciclib + Herceptin for HER2+ MBCWithdrawnNCT03846583Phase 1
- Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.Status unknownNCT03843749Not applicable
- Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular CarcinomaCompletedNCT03841201Phase 2
- Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung CancerStatus unknownNCT03841136Phase 2
- Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical ResectionStatus unknownNCT03839550Phase 2
- Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/ParagangliomaActive, not recruitingNCT03839498Phase 2
- Ponatinib in Advanced or Metastatic Medullary Thyroid CancerWithdrawnNCT03838692Phase 2
- BTK Inhibitor DTRMWXHS-12 in Mantle Cell LymphomaCompletedNCT03836768Phase 1
- Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLLActive, not recruitingNCT03836261Phase 3
- Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI ResistanceActive, not recruitingNCT03833440Phase 2
- FGFR Inhibitor in FGFR Dysregulated CancerTerminatedNCT03827850Phase 2
- Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological TumorsStatus unknownNCT03827837Phase 2
- A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTSCompletedNCT03827668Phase 1
- Ibrutinib in Steroid Refractory Autoimmune Hemolytic AnemiaStatus unknownNCT03827603Phase 2
- Dry Pleurodesis With Talcum and Afatinib is Used to Treat Patients With Non-Small Cell Lung CarcinomaStatus unknownNCT03827070Phase 1
- Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and ChildrenCompletedNCT03826901Phase 1
- A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on MetforminCompletedNCT03826602Phase 1
- Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based ChemotherapyCompletedNCT03826589Not applicable
- A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular CarcinomaStatus unknownNCT03825705Phase 1/2
- hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"Status unknownNCT03824691Phase 2
- Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)Active, not recruitingNCT03824483Phase 2
- Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic SyndromesCompletedNCT03824080Phase 2
- S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung CancerCompletedNCT03823118Phase 2
- Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single-Dose of PF-06651600 in Healthy ParticipantsCompletedNCT03821493Phase 1
- Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ CancerStatus unknownNCT03817411Phase 2
- Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid LeukemiaActive, not recruitingNCT03817398Phase 2
- SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical CancerCompletedNCT03816553Phase 2
- Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma PatientsStatus unknownNCT03815474Phase 2
- A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic TherapyCompletedNCT03813784Phase 3
- A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation PositiveCompletedNCT03812809Phase 2
- Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative BreastActive, not recruitingNCT03812393Phase 2
- An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 MutationStatus unknownNCT03810872Phase 2
- Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung CancerCompletedNCT03810807Phase 1
- Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS)CompletedNCT03810066Phase 2
- Study in Patients With Chronic LeukemiaTerminatedNCT03807479Phase 2
- Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy ParticipantsCompletedNCT03806101Phase 1
- FUSCC Refractory TNBC Umbrella (FUTURE)Status unknownNCT03805399Phase 1/2
- First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung CancerActive, not recruitingNCT03804580Phase 2
- The Absorption, Metabolism and Excretion of [14C]Ensartinib in HumanStatus unknownNCT03804541Phase 1
- Lenvatinib for Unresectable Intrahepatic CholangiocarcinomaWithdrawnNCT03801499Phase 2
- Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic DisordersActive, not recruitingNCT03801434Phase 2
- Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLCStatus unknownNCT03801200Phase 2
- Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLCStatus unknownNCT03799601Phase 4
- A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue SarcomaCompletedNCT03798106Phase 2
- A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)CompletedNCT03797456Phase 2
- Ruxolitinib Combined With Dexamethasone for HLHStatus unknownNCT03795909Phase 1/2
- A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCCStatus unknownNCT03793725Phase 2
- Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the BloodActive, not recruitingNCT03793478Phase 1/2
- Phase II Study of Regorafenib as Maintenance TherapyCompletedNCT03793361Phase 2